GENERTEC UNIVERSAL MEDICAL GROUP COMPANY LIMITED 通用環球醫療集團有限公司 (Incorporated in Hong Kong with Limited Liability) (Stock Code:2666)
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. GENERTEC UNIVERSAL MEDICAL GROUP COMPANY LIMITED 通用環球醫療集團有限公司 (Incorporated in Hong Kong with limited liability) (Stock Code:2666) SUPPLEMENTAL ANNOUNCEMENT CAPITAL INCREASE IN A SUBSIDIARY Reference is made to the announcement of Genertec Universal Medical Group Company Limited (the “Company”) dated 1 June 2020 (the “Announcement”) in respect of a capital increase in a subsidiary of the Company. Capitalized terms used herein shall have the same meanings as those defined in the Announcement unless otherwise stated. Identities of the Ultimate Beneficial Owners of the Relevant Parties Further to the information of the Parties under the Capital Increase Agreement disclosed in the Announcement, to the best knowledge, information and belief of the Directors having made all reasonable enquiry, (a) the ultimate beneficial owner of each of the Minmetals Investors and Minmetals Innovation Investment is China Minmetals Corporation, a state-owned corporation under direct supervision of SASAC; and (b) the holding company of CITIC Capital (Tianjin) is CITIC Capital Holdings Limited (“CITIC Capital”). CITIC Capital is effectively owned by institutional shareholders, which include CITIC Limited (0267.HK, 19.90%), Tencent Holdings Limited (0700.HK, 20.70%), Fubon Financial Holding Co., Ltd. and its affiliate (2881.TW, 19.92%), Qatar Holding LLC (sovereign wealth fund of Qatar, 18.73%), and its management (managing director and above, 20.75%).
[Show full text]